These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11956239)

  • 21. Epigenetic States of nephron progenitors and epithelial differentiation.
    Adli M; Parlak M; Li Y; El-Dahr SS
    J Cell Biochem; 2015 Jun; 116(6):893-902. PubMed ID: 25560433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model.
    Murphy KL; Dennis AP; Rosen JM
    FASEB J; 2000 Nov; 14(14):2291-302. PubMed ID: 11053251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
    Abadir PM; Carey RM; Siragy HM
    Hypertension; 2003 Oct; 42(4):600-4. PubMed ID: 12953015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 regulates the self-renewal and differentiation of neural precursors.
    Armesilla-Diaz A; Bragado P; Del Valle I; Cuevas E; Lazaro I; Martin C; Cigudosa JC; Silva A
    Neuroscience; 2009 Feb; 158(4):1378-89. PubMed ID: 19038313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
    Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
    Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription.
    Zhao J; Schmieg FI; Logsdon N; Freedman D; Simmons DT; Molloy GR
    Oncogene; 1996 Jul; 13(2):293-302. PubMed ID: 8710368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation.
    Pierce A; Spooncer E; Wooley S; Dive C; Francis JM; Miyan J; Owen-Lynch PJ; Dexter TM; Whetton AD
    Oncogene; 2000 Nov; 19(48):5487-97. PubMed ID: 11114726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two promoters that map to 5'-sequences of the human p53 gene are differentially regulated during terminal differentiation of human myeloid leukemic cells.
    Reisman D; Rotter V
    Oncogene; 1989 Aug; 4(8):945-53. PubMed ID: 2668845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
    Thomas M; Matlashewski G; Pim D; Banks L
    Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compromised HOXA5 function can limit p53 expression in human breast tumours.
    Raman V; Martensen SA; Reisman D; Evron E; Odenwald WF; Jaffee E; Marks J; Sukumar S
    Nature; 2000 Jun; 405(6789):974-8. PubMed ID: 10879542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference with p53 protein inhibits hematopoietic and muscle differentiation.
    Soddu S; Blandino G; Scardigli R; Coen S; Marchetti A; Rizzo MG; Bossi G; Cimino L; Crescenzi M; Sacchi A
    J Cell Biol; 1996 Jul; 134(1):193-204. PubMed ID: 8698814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of integrins in the assembly and function of hensin in intercalated cells.
    Vijayakumar S; Erdjument-Bromage H; Tempst P; Al-Awqati Q
    J Am Soc Nephrol; 2008 Jun; 19(6):1079-91. PubMed ID: 18337486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells.
    Mazzaro G; Bossi G; Coen S; Sacchi A; Soddu S
    Oncogene; 1999 Oct; 18(42):5831-5. PubMed ID: 10523864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin-based mechanisms of renal epithelial differentiation.
    Surendran K; Kopan R
    J Am Soc Nephrol; 2011 Jul; 22(7):1208-12. PubMed ID: 21700830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional control of epithelial differentiation during kidney development.
    Ribes D; Fischer E; Calmont A; Rossert J
    J Am Soc Nephrol; 2003 Jun; 14 Suppl 1():S9-15. PubMed ID: 12761232
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting tumor suppressor p53 for organ fibrosis therapy.
    Bao YN; Yang Q; Shen XL; Yu WK; Zhou L; Zhu QR; Shan QY; Wang ZC; Cao G
    Cell Death Dis; 2024 May; 15(5):336. PubMed ID: 38744865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the Art of Pharmacological Activators of p53 in Ocular Malignancies.
    Casciano F; Zauli E; Busin M; Caruso L; AlMesfer S; Al-Swailem S; Zauli G; Yu AC
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell Death in the Kidney.
    Priante G; Gianesello L; Ceol M; Del Prete D; Anglani F
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.